[ home ]
:archives

:bionetworking: techjournal event
:asklepios: gene therapy firm
covering biotech and pharma

interviews, news, research, and features about biotech, pharma, and more

the country;s only biotech tv show!

2002 tranzyme interview

in may of 2005, tranzyme received $32 million in funding.

in this 2002 interview, we talked with Dr. Vipin Garg of genetic firm Tranzyme, about their use of viruses (called vectors) to deliver genetic code more efficiently into the nucleus of cells.  their process makes it easier to introduce genetic code into both cells and even living mammals.

2002 tranzyme interview

in may of 2005, tranzyme received $32 million in funding.

in this 2002 interview, we talked with Dr. Vipin Garg of genetic firm Tranzyme, about their use of viruses (called vectors) to deliver genetic code more efficiently into the nucleus of cells.  their process makes it easier to introduce genetic code into both cells and even living mammals.

covering biotech and pharma

interviews, news, research, and features about biotech, pharma, and more

the country;s only biotech tv show!

:archives

:bionetworking: techjournal event
:asklepios: gene therapy firm
[ home ]
">
">
">
">
the biotech channel has been brought to you by:
:the research triangle's tv station
:viewers in 87 countries and counting